RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Benedik's purchase was likely related to Cortex's 30,000 share minimum ownership requirement for management. His shares now equal exactly 30,000.

Neuro, BTW, any thoughts on Cypress' newly approved fibromyalgia drug Savella? Looks like it may have more cardio side effects than current treatments like Cymbalta, but some analysts are predicting it will take a big share of the market. Looks like Cypress will get a 15% royalty from Forest on US sales.